Early ribavarin treatment of bronchiolitis: Effect on long-term respiratory morbidity

Chest

Volumn 122, Issue 3, 2002, Pages 935-939

  Edell, Dean ^a   Khoshoo, Vikram ^a   Ross, Gerald ^a   Salter, Karen ^a  

^a West Jefferson Medical Center   (United States)

Author keywords

Bronchiolitis; Reactive airway disease; Respiratory syncytial virus; Ribavirin

Indexed keywords

METHYLPREDNISOLONE; RANITIDINE; RIBAVIRIN; SALBUTAMOL;

ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

EID: 0036382645     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.3.935     Document Type: Article

References (22)

1. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children: Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992; 121:348-354
2. Long CE, McBride JT, Hall CB. Sequelae of respiratory syncytial virus infections: a role for intervention studies. Am J Respir Crit Care Med 1995; 151:1678-1681
3. Reassessment of indications for ribavirin therapy in respiratory syncytial virus infections: American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1996; 97:137-140
4. Krilov LR, Mandel FS, Barone SR, et al. Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long-term pulmonary function. Pediatr Infect Dis 1997; 16:273-276
5. Long CE, Voter KZ, Barker WH, et al. Long-term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. Pediatr Infect Dis 1997; 16:1023-1028
6. Fergie JE. Effects of ribavirin therapy on RSV infections in high-risk infants and young children 2 years after hospitalization. In: Hiatt PW, ed. RSV and asthma: is there a link? New York, NY: American Thoracic Society, 1998; 46-50
7. Edell DS, Bruce E, Hale K, et al. Reduced long-term morbidity after treatment of respiratory syncytial virus bronchiolitis with and without ribavirin in previously healthy infants: a preliminary report. Pediatr Pulmonol 1998; 25:154-158
8. Hiatt P, Treece D, Morris L, et al. Longitudinal pulmonary function following treatment with ribavirin in infants hospitalized with RSV bronchiolitis [abstract]. Am J Respir Crit Care Med 1994; 149:A354
9. Rodriguez WJ, Arrobio J, Fink R, et al. Prospective follow-up and pulmonary function from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Arch Pediatr Adolesc Med 1999; 153:469-474
10. Rodriguez WJ, Fink RA, Ottolini M, et al. Bronchial reactivity 8-15 years after respiratory syncytial virus lower respiratory tract infection [abstract]. Pediatr Res 1999; 45:172A
11. Englund JA, Piedra PA, Jefferson LS, et al. High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1990; 117:313-320
12. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354:527-528
13. Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis 1999; 18:115-122
14. Carubelli CM, Jafri HS, Sanchez PJ, et al. Ribavirin suppresses pro-inflammatory cytokine production in pulmonary epithelial cells infected with respiratory syncytial virus [abstract]. Pediatr Res 1999; 45:158A
15. Khoshoo V, Edell D. Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics 1999; 104:1389-1390
16. Gelfand AS, Larsen GL, Loader JE, et al. Effect of aspiration of milk on mechanisms of neural control in the airway of developing rabbits. Pediatr Pulmonol 1997; 23:198-204
17. Colombo JL, Hallberg TK. Airway reactivity following repeated aspiration in rabbits. Pediatr Pulmonol 2000; 29:113-119
18. Khoshoo V, Kelly B, Ross G, et al. Benefits of thickened feeds in previously healthy infants with respiratory syncytial viral bronchiolitis. Pediatr Pulmonol 2001; 31:301-302
19. Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999; 104:e77
20. van Woensel JB, Wolfs TF, van Aalderen WM, et al. Randomized double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997; 52:634-637
21. van Woensel JB, Kimpen JL, Sprikkelman AB, et al. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus. Pediatr Pulmonol 2000; 30:92-96
22. Prince GA, Mathews A, Curtis SJ, et al. Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody and glucocorticoid. J Infect Dis 2000; 182:1326-1330